BioMarin Pharmaceutical Inc (BMRN) Net margin 2016–2025
BioMarin Pharmaceutical Inc (BMRN) net profit margin by fiscal year — reported net income divided by reported revenue.
10.8%FY2025 · since FY2016: -56.4% → 10.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 10.8% | -4.1 pp |
| FY2024 | 15.0% | +8.0 pp |
| FY2023 | 6.9% | +0.2 pp |
| FY2022 | 6.8% | +10.2 pp |
| FY2021 | -3.5% | -49.4 pp |
| FY2020 | 45.9% | +47.3 pp |
| FY2019 | -1.4% | +3.8 pp |
| FY2018 | -5.2% | +3.7 pp |
| FY2017 | -8.9% | +47.5 pp |
| FY2016 | -56.4% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice